FDA greenlights Omicron to target COVID booster ahead of re-vaccination campaign

FDA greenlights Omicron to target COVID booster ahead of re-vaccination campaign

Sign up now for free and unlimited access to Reuters.com register Aug 31 (Reuters) – The U.S. Food and Drug Administration on Wednesday authorized Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna to update COVID-19 for major BA.4 and BA.5 Omicron sub-variants A booster as the government prepares for a broad fall vaccination campaign that could begin within …

FDA greenlights Omicron to target COVID booster ahead of re-vaccination campaign Read More »